Composition for Improving Atopy Dermatitis Using an Extract of Rudbeckia laciniata
Disclosed in the present invention is a composition for alleviating atopic dermatitis using an extract of Rudbeckia laciniata that exhibits MDC and TARC expression inhibitory activity when treated with HaCaT cells, a human keratinocyte cell line treated with INF-γ and TNF-α. 본 발명은 INF-γ와 TNF-α로 처리된...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
13.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed in the present invention is a composition for alleviating atopic dermatitis using an extract of Rudbeckia laciniata that exhibits MDC and TARC expression inhibitory activity when treated with HaCaT cells, a human keratinocyte cell line treated with INF-γ and TNF-α.
본 발명은 INF-γ와 TNF-α로 처리된 인간각질형성세포주인 HaCaT 세포에 처리될 때 MDC 및 TARC 발현 억제 활성을 보이는 삼립국화 추출물을 이용한 아토피 피부염 개선용 조성물을 개시한다. |
---|---|
Bibliography: | Application Number: KR20210173314 |